2022 annual financial data
Abeona Therapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,075.18%.
Operating income was -50,915,000 USD and net income was -39,696,000 USD.
Operating cash flow was -43,483,000 USD.
Get free Abeona Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,414,000 USD
- Operating income
- -50,915,000 USD
- Net income
- -39,696,000 USD
- Operating cash flow
- -43,483,000 USD